Need professional-grade analysis? Visit stockanalysis.com
$9.54M
N/A
57
N/A
bioAffinity Technologies, Inc. (BIAF) trades on United States in USD. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at $2.30, down 8.37% from the previous close.
Over the past year, BIAF has traded between a low of $0.75 and a high of $14.97. The stock has lost 84.6% over this period. It is currently 84.6% below its 52-week high.
bioAffinity Technologies, Inc. has a market capitalization of $9.54M.
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. It operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.
Side-by-side comparison against top Healthcare peers.